Åsa Riisberg



Åsa has been a board member since March 2022 and was previous a Partner at EQT AB with extensive experience from private equity and the investment industry with focus on long-term value creation. Previously, she was an Investment Professional at TPG Capital and Morgan Stanley. She is currently a Director of the boards of Atlas Antibodies,  Bonnier News, Dagens Nyheter, Internetmedicin, Netcompany and Vifor Pharma and Strategic Advisory Board member at Chiesi Pharma and an Advisory Board member at MFIN at Stockholm School of Economics

She has extensive prior board experience including e.g. Aleris, Atos Medical, F-Secure, Karo Pharma and Terveystalo.

Åsa holds a MSc from the School of Economics in Stockholm, Sweden.